QR-110
Showing 1 - 25 of 551
Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia, Ghent (QR-110)
Active, not recruiting
- Leber Congenital Amaurosis 10
- +9 more
- QR-110
-
Iowa City, Iowa
- +2 more
Feb 8, 2022
Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen, Sham)
Active, not recruiting
- Leber Congenital Amaurosis 10
- +9 more
- sepofarsen
- Sham
-
Iowa City, Iowa
- +13 more
Mar 2, 2022
Leber's Congenital Amaurosis Trial in Iowa City, Philadelphia, Ghent (QR-110)
Completed
- Leber's Congenital Amaurosis
- QR-110
-
Iowa City, Iowa
- +2 more
Oct 13, 2020
Pain Trial (GoodFOR Pain, Icy Hot, Tiger Balm)
Not yet recruiting
- Pain
- GoodFOR Pain
- +7 more
- (no location specified)
Jun 6, 2022
Head Neck Cancer, Quality of Life, Pain Trial in Kaohsiung (Hydrogen Inhalation, Ordinary Air Inhalation)
Recruiting
- Head and Neck Cancer
- +4 more
- Hydrogen Inhalation
- Ordinary Air Inhalation
-
Kaohsiung, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital
Feb 10, 2023
Bunion Trial in Bellaire (Ropivacaine)
Recruiting
- Bunion
-
Bellaire, TexasFirst Surgical Hospital 4801 Bissonnet Street
Mar 6, 2023
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose
Completed
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure (dose cohort 1&2 only)
-
Boston, Massachusetts
- +6 more
Apr 19, 2022
Contraceptive Usage Trial in Fort Worth (Tuune Supplemented Contraceptive Visit, Traditional Contraceptive Visit)
Not yet recruiting
- Contraceptive Usage
- Tuune Supplemented Contraceptive Visit
- Traditional Contraceptive Visit
-
Fort Worth, TexasTexas Christian University
Jul 31, 2023
Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for
Terminated
- Retinitis Pigmentosa
- Usher Syndrome Type 2
- RNA antisense oligonucleotide for intravitreal injection
-
Boston, Massachusetts
- +6 more
Dec 12, 2022
Musculoskeletal Diseases or Conditions Trial (Educational Tool)
Not yet recruiting
- Musculoskeletal Diseases or Conditions
- Educational Tool
- (no location specified)
Jun 19, 2023
Refractory Chronic Cough Trial in Phoenix, Leesburg, Winter Park (3 mg NOC-100 (via nebulizer), 1 mg NOC-110 (via DPI) [1x 1 mg
Completed
- Refractory Chronic Cough
- 3 mg NOC-100 (via nebulizer)
- +5 more
-
Phoenix, Arizona
- +2 more
Nov 16, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)
Active, not recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure
-
Dallas, Texas
- +2 more
Apr 21, 2022
Cardiopulmonary Function and Quality of Life in Patients
Active, not recruiting
- COVID-19
- None intervation
-
Lima Lima, Lima, PeruInstituto de Medicina Tropical Alexander von Humboldt, Universid
Aug 28, 2022
Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)
Terminated
- Acute Myeloid Leukemia
- Myeloid Dysplastic Syndrome
-
Buffalo, New York
- +20 more
Jan 21, 2022
Blood Pressure, Perioperative Hypotension Trial in Hamburg (Continuous norepinephrine infusion via an infusion pump, Manual
Not yet recruiting
- Blood Pressure
- Perioperative Hypotension
- Continuous norepinephrine infusion via an infusion pump
- Manual bolus norepinephrine administration
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Aug 10, 2023
Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- OCU-10-C-110 for Injection
-
Abilene, TexasRetina Research Institute of Texas
Jun 6, 2023
Atrial Fibrillation, Hemostasis Trial in Overland Park, Independence, Kansas City (Vascular closure with LockeT device)
Recruiting
- Atrial Fibrillation
- Hemostasis
- Vascular closure with LockeT device
-
Overland Park, Kansas
- +5 more
Oct 3, 2023
Heart Failure Trial in Shatin (Dapagliflozin)
Not yet recruiting
- Heart Failure
-
Shatin, Hong KongThe Chinese University of Hong Kong
Feb 24, 2023
Glabellar Frown Lines Trial in Seoul (ATGC-110, Xeomin®)
Active, not recruiting
- Glabellar Frown Lines
- ATGC-110
- Xeomin®
-
Seoul, Korea, Republic ofNowon Eulji Medical Center
Feb 2, 2023
Food Insecurity Trial in San Francisco (Monetary benefit to purchase fruits and vegetables)
Not yet recruiting
- Food Insecurity
- Monetary benefit to purchase fruits and vegetables
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 28, 2023
Methylmalonic Acidemia (MMA) Trial run by the Selecta Biosciences, Inc. (SEL-302)
Recruiting
- Methylmalonic Acidemia (MMA)
-
Bethesda, MarylandNational Human Genome Research Institute, National Institutes of
Mar 9, 2023